Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C

Telaprevir (TVR) is used for the treatment of chronic hepatitis C in a combination therapy with pegylated-interferon and ribavirin. Although renal dysfunction is one of the critical adverse outcomes of this treatment, little is known regarding the mechanism of its onset. The present study assessed t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Exp Ther Med
Glavni autori: KOHJIMA, MOTOYUKI, KUROKAWA, MIHO, ENJOJI, MUNECHIKA, YOSHIMOTO, TSUYOSHI, NAKAMURA, TSUKASA, OHASHI, TOMOKO, FUKUIZUMI, KUNITAKA, HARADA, NAOHIKO, MURATA, YUSUKE, MATSUNAGA, KAZUHISA, KATO, MASAKI, KOTOH, KAZUHIRO, NAKAMUTA, MAKOTO
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2016
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840744/
https://ncbi.nlm.nih.gov/pubmed/27168803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3133
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items